A putative role for the immunoproteasome in the maintenance of pluripotency in human embryonic stem cells

Stem Cells

Volumn 30, Issue 7, 2012, Pages 1373-1384

  Atkinson, Stuart P ^a,b   Collin, Joseph ^a   Irina, Neganova ^a   Anyfantis, George ^a   Kyung, B O Kim ^c   Lako, Majlinda ^a   Armstrong, Lyle ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Human embryonic stem cells; Immunoproteasome; Maintenance of pluripotency; Proteasome

Indexed keywords

IMMUNOPROTEASOME; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; PROTEASOME; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PLURIPOTENCY; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EMBRYONIC STEM CELL; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SUBUNIT;

BLOTTING, WESTERN; CELL CYCLE; CELL DIFFERENTIATION; CYSTEINE ENDOPEPTIDASES; EMBRYONIC STEM CELLS; HUMANS; PLURIPOTENT STEM CELLS; PROTEASOME ENDOPEPTIDASE COMPLEX; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84862840388     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1113     Document Type: Article

References (44)

1. Hyslop LA, Armstrong L, Stojkovic M et al. Human embryonic stem cells: Biology and clinical implications. Expert Rev Mol Med 2005;7: 1-21.
2. Saretzki G, Armstrong L, Leake A et al. Stress defense in murine embryonic stem cells is superior to that of various differentiated murine cells. Stem Cells 2004;22:962-971. (Pubitemid 39507083)
3. Saretzki G, Walter T, Atkinson S et al. Downregulation of multiple stress defense mechanisms during differentiation of human embryonic stem cells. Stem Cells 2008;26:455-464. (Pubitemid 351413606)
4. Armstrong L, Tilgner K, Saretzki G et al. Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells. Stem Cells 2010;28:661-673.
5. Stambrook PJ, Tichy ED. Preservation of genomic integrity in mouse embryonic stem cells. Adv Exp Med Biol 2010;695:59-75.
6. Neganova I, Vilella F, Atkinson SP et al. An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells. Stem Cells 2011;29:651-659.
7. Davies KJ. Degradation of oxidized proteins by the 20S proteasome. Biochimie 2001;83:301-310. (Pubitemid 32293650)
8. Breusing N, Grune T. Regulation of proteasome-mediated protein degradation during oxidative stress and aging. Biol Chem 2008;389: 203-209. (Pubitemid 351329027)
9. Crawford LJ, Walker B, Irvine AE. Proteasome inhibitors in cancer therapy. J Cell Commun Signal 2011;5:101-110.
10. Baharvand H, Hajheidari M, Ashtiani SK et al. Proteomic signature of human embryonic stem cells. Proteomics 2006;6:3544-3549. (Pubitemid 44000184)
11. Assou S, Cerecedo D, Tondeur S et al. A gene expression signature shared by human mature oocytes and embryonic stem cells. BMC Genomics 2009;10:10.
12. Szutorisz H, Georgiou A, Tora L et al. The proteasome restricts permissive transcription at tissue-specific gene loci in embryonic stem cells. Cell 2006;127:1375-1388. (Pubitemid 44960411)
13. Ciechanover A. The ubiquitin-proteasome pathway: On protein death and cell life. EMBO J 1998;17:7151-7160. (Pubitemid 29002684)
14. Tanaka K, Kasahara M. The MHC class I ligand-generating system: Roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28. Immunol Rev 1998;163:161-176. (Pubitemid 28327869)
15. Früh K, Yang Y. Antigen presentation by MHC class I and its regulation by interferon gamma. Curr Opin Immunol 1999;11: 76-81. (Pubitemid 29082341)
16. Chen X, Barton LF, Chi Y et al. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol Cell 2007; 26:843-852. (Pubitemid 46921008)
17. Chondrogianni N, Stratford FL, Trougakos IP et al. Central role of the proteasome in senescence and survival of human fibroblasts: Induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. J Biol Chem 2003;278: 28026-28037. (Pubitemid 36899999)
18. Fucci L, Oliver CN, Coon MJ et al. Inactivation of key metabolic enzymes by mixed-function oxidation reactions: Possible implication in protein turnover and ageing. Proc Natl Acad Sci USA 1983;80: 1521-1525. (Pubitemid 13052442)
19. Keller JN, Schmitt FA, Scheff SW et al. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 2005;64:1152-1156.
20. Shang F, Taylor A. Oxidative stress and recovery from oxidative stress are associated with altered ubiquitin conjugating and proteolytic activities in bovine lens epithelial cells. Biochem J 1995;307: 297-303.
21. Whittier JE, Xiong Y, Rechsteiner MC et al. Hsp90 enhances degradation of oxidized calmodulin by the 20 S proteasome. J Biol Chem 2004;279:46135-46142. (Pubitemid 39491608)
22. Ahn K, Erlander M, Leturcq D et al. In vivo characterization of the proteasome regulator PA28. J Biol Chem 1996;271: 18237-18242. (Pubitemid 26250818)
23. Davies KJ. Degradation of oxidized proteins by the 20S proteasome. Biochimie 2001;83:301-310. (Pubitemid 32293650)
24. Thomas S, Kotamraju S, Zielonka J et al. Hydrogen peroxide induces nitric oxide and proteosome activity in endothelial cells: A bell-shaped signaling response. Free Radic Biol Med 2007;42: 1049-1061. (Pubitemid 46356897)
25. Wang X, Yen J, Kaiser P et al. Regulation of the 26s proteasome complex during oxidative stress. Sci Signal 2010;3:ra88.
26. Stojkovic M, Lako M, Stojkovic P et al. Derivation of human embryonic stem cells from day-8 blastocysts recovered after three-step in vitro culture. Stem Cells 2004;225:790-797. (Pubitemid 39166936)
27. Kisselev AF, Garcia-Calvo M, Overkleeft HS et al. The caspase-like sites of proteasomes, their substrate specificity, new inhibitors and substrates, and allosteric interactions with the trypsin-like sites. J Biol Chem 2003;278:35869-35877. (Pubitemid 37139904)
28. Schrader EK, Harstad KG, Matouschek A. Targeting proteins for degradation. Nat Chem Biol 2009;5:815-822.
29. Lako M, Neganova I, Armstrong L. G1 to S transition and pluripotency: Two sides of the same coin? Cell Cycle 2009;8: 1108-1109.
30. Zhang X, Neganova I, Przyborski S et al. A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A. J Cell Biol 2009;184:67-82.
31. Neganova I, Zhang X, Atkinson S et al. Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells. Oncogene 2009;28:20-30.
32. Ho YK, Bargagna-Mohan P, Wehenkel M et al. LMP2-specific inhibitors: Chemical genetic tools for proteasome biology. Chem Biol 2007; 14:419-430. (Pubitemid 46617320)
33. Muchamuel T, Basler M, Aujay MA et al. A selective inhibitor of the immunoproteasome subunit LMP7 blocks the cytokine production and attenuates progression of experimental arthritis. Nat Med 2009;15: 781-787.
34. Maimets T, Neganova I, Armstrong L et al. Activation of p53 by nutlin leads to rapid differentiation of human embryonic stem cells. Oncogene 2008;27:5277-5287.
35. Xu H, Wang W, Li C et al. WWP2 promotes degradation of transcription factor OCT4 in human embryonic stem cells. Cell Res 2009;19: 561-573.
36. Szutorisz H, Dillon N, Tora L. [Suppression of non-specific transcription by the proteasome in embryonic stem cells]. Med Sci (Paris) 2007;23:351-353.
37. Hernebring M, Brolén G, Aguilaniu H et al. Elimination of damaged proteins during differentiation of embryonic stem cells. Proc Natl Acad Sci USA 2006;103:7700-7705.
38. Pickering AM, Koop AL, Teoh CY et al. The immunoproteasome, the 20S proteasome and the PA28αβ proteasome regulator are oxidative-stress-adaptive proteolytic complexes. Biochem J 2010;432: 585-594.
39. Hussong SA, Kapphahn RJ, Phillips SL et al. Immunoproteasome deficiency alters retinal proteasome's response to stress. J Neurochem 2010;113:1481-1490.
40. Fehling HJ, Swat W, Laplace C et al. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 1994;265:1234-1237. (Pubitemid 24291982)
41. Van Kaer L, Ashton-Rickardt PG, Eichelberger M et al. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1994;1:533-541.
42. Becker KA, Stein JL, Lian JB et al. Human embryonic stem cells are pre-mitotically committed to self-renewal and acquire a lengthened G1 phase upon lineage programming. J Cell Physiol 2010;222:103-110.
43. Kim MO, Kim SH, Cho YY et al. ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4. Nat Struct Mol Biol 2012;19:283-290.
44. Jiang Y, Cowley SA, Siler U et al. Derivation and functional analysis of patient specific induced pluripotent stem cells as an in vitro model of chronic granulomatous disease. Stem Cells 2012;30:599-611.